Trademark: 97124968
Word
NGMBIO
Status Date
Friday, November 17, 2023
Filing Date
Monday, November 15, 2021
Published for Opposition
Tuesday, May 9, 2023
5 Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
44 Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
42 Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
The mark consists of the combined words "ngmBIO" with "ngm" in lowercase stylized letters and "BIO" in uppercase stylized letters.
Color is not claimed as a feature of the mark.
"BIO"
Nov 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 17, 2023
Sou Extension 1 Granted
Nov 17, 2023
Sou Extension 1 Filed
Nov 17, 2023
Sou Teas Extension Received
Jul 4, 2023
Noa E-Mailed - Sou Required From Applicant
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Mar 31, 2023
Approved For Pub - Principal Register
Mar 18, 2023
Examiner's Amendment Entered
Mar 18, 2023
Assigned To Lie
Mar 17, 2023
Notification Of Examiners Amendment E-Mailed
Mar 17, 2023
Examiners Amendment E-Mailed
Mar 17, 2023
Examiners Amendment -Written
Mar 1, 2023
Notification Of Non-Final Action E-Mailed
Mar 1, 2023
Non-Final Action E-Mailed
Mar 1, 2023
Non-Final Action Written
Feb 2, 2023
Teas/Email Correspondence Entered
Feb 1, 2023
Correspondence Received In Law Office
Feb 1, 2023
Teas Response To Office Action Received
Aug 8, 2022
Notification Of Non-Final Action E-Mailed
Aug 8, 2022
Non-Final Action E-Mailed
Aug 8, 2022
Non-Final Action Written
Aug 4, 2022
Assigned To Examiner
Nov 19, 2021
New Application Office Supplied Data Entered
Nov 18, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
